Although ellagic acid has been already known as anti-cancer agent, this is the first study that demonstrated that ellagic acid acts as tumor-metabolism modulator, binds with PKM2 at the active site, and inhibits its activity in cancer cells. The gene discussed is PKM; the disease is neoplasm.